Key Drivers
- Margin Stability
- Cash Flow Swing
- Debt Load
AIAI Summary
SEM should be viewed as a deal-driven special situation, not a standalone growth play: with the $16.50 all-cash offer and HSR clearance anchoring value, the main trade is to capture the merger price while monitoring litigation, fairness scrutiny, and any delay or renegotiation risk that could erode the capped upside.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin Stability
- •Cash Flow Swing
- •Debt Load
SEM combines steady margins and moderate valuation with strong full-year cash flow, but high leverage and a negative latest-quarter free cash flow make execution risk the key watchpoint.
Price Behavior
Key Price Behavior Insights:
- •Tight Range
- •Failed Breakout
- •Clear Support
SEM has been essentially flat over the last month, trading in a tight $16.49-$16.66 range with support at $16.49-$16.50 and resistance near $16.65-$16.66, signaling consolidation and a failed breakout attempt.
Brief mid-June push to $16.66 faded, followed by small-step drift lower
Sentiment & News
Key News Insights:
- •M&A scrutiny
- •Fiduciary concerns
- •Price fairness
SEM headlines are dominated by repeated shareholder-law investigations into whether the $16.50-per-share Select Medical sale to an insider-linked buyer is fair and properly approved.
The news flow is likely a headwind for SEM as it raises legal overhang and may pressure investor confidence in the transaction
Similar Companies in Healthcare
Other companies in the same sector with AI ratings